Oral administration of the prominent gut microbe Faecalibacterium prausnitzii has recently been discovered to show anti-inflammatory properties by increasing the production of IL-10 (a cytokine) and tumor necrosis factor (TNF) in the colon to improve intestinal disease [9]. This evidence concerns the gene TNF and intestinal disorder.